Walgreens beats Q3 estimates and plans to go private in a $10 billion deal

From Financial Modeling Prep: 2025-06-26 16:34:00

Walgreens Boots Alliance (NASDAQ:WBA) exceeded expectations in Q3 with a $0.38 adjusted EPS, beating the $0.31 consensus. Sales reached $39 billion, up 7.2% YoY and surpassing estimates of $36.79 billion. The pharmacy chain is set to go private in a $10 billion deal with Sycamore Partners, pending regulatory and shareholder approval.

The pending privatization has led Walgreens to withhold financial guidance. The deal is anticipated to close in late 2025, resulting in the delisting of Walgreens shares from the Nasdaq. The company’s struggles with shrinking drug margins and tough competition from retail giants have prompted aggressive cost-cutting measures under CEO Tim Wentworth.

Walgreens, once valued at $100 billion, has faced challenges from retail rivals like Walmart and Amazon. To combat these pressures, the company has embarked on a cost-saving strategy that includes store closures and a target of $1 billion in annual savings.



Read more at Financial Modeling Prep:: Walgreens Tops Q3 Estimates Amid Cost Cuts Ahead o…